Demonstration of a Tissue Factor Pathway Inhibitor 2 Messenger RNA Synthesis by Pure Villous Cytotrophoblast Cells Isolated from Term Human Placentas1
Open Access
- 1 May 2003
- journal article
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 68 (5) , 1888-1894
- https://doi.org/10.1095/biolreprod.102.011858
Abstract
Tissue factor pathway inhibitor 2 (TFPI-2), a Kunitz-type proteinase inhibitor, might play an important role during placenta growth by regulating trophoblast invasion and differentiation. Many TFPI-2 transcripts have been detected in syncytiotrophoblast cells, but conflicting results have been reported concerning TFPI-2 synthesis by the cytotrophoblast. To address this issue, we developed a method to isolate pure preparations of human villous cytotrophoblast cells from normal term placentas, and the synthesis of tissue factor, TFPI-1, and TFPI-2 mRNAs was then evaluated. Cells were isolated by trypsin-DNase-EDTA digestion, followed by Percoll gradient separation and immunodepletion of human leukocyte antigen-positive cells. The quality of villous cytotrophoblast cells was verified by electron microscopy. Purity of cell preparations was assessed by labeling cells with GB25, a monoclonal antibody specific to villous trophoblast cells, and by checking the absence of contaminating cells using anti-CD9 antibody. The lack of hCG, CD32 mRNA, and tissue factor mRNA also indicated the absence of contaminating cells. Using competitive reverse transcription polymerase chain reaction, we showed that freshly isolated villous cytotrophoblast cells synthesized significant levels of TFPI-1 mRNA and larger amounts of TFPI-2 mRNA. TFPI-1 and TFPI-2 mRNA synthesis remained unchanged when cytotrophoblast cells were cultured in complete medium and evolved as a multinucleated syncytiotrophoblast. These results indicate that the villous cytotrophoblast and syncytiotrophoblast are both important sites of TFPI-2 synthesis in the human placenta. This study also indicates that tissue factor detection should be used systematically to check the purity of cytotrophoblast cell preparations because it allows detection of contamination by monocytes/macrophages and by syncytial fragments.Keywords
This publication has 34 references indexed in Scilit:
- Subcellular Localization of PP5/TFPI-2 in Human Placenta: A Possible Role of PP5/TFPI-2 as an Anti-coagulant on the Surface of SyncytiotrophoblastsPlacenta, 2002
- Expression of tissue factor pathway inhibitor in human fetal and placental tissuesEarly Human Development, 2000
- Increase in expression and activity of thrombomodulin in term human syncytiotrophoblast microvilliPlacenta, 1998
- Specific expression of PP5/TFPI-2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridizationPlacenta, 1998
- Anchoring villi in human placental basal plate: Lymphocytes, macrophages and coagulationPlacenta, 1991
- Tissue factor: identification and characterization of cell types in human placentaeBlood, 1990
- Purification and characterization of placental protein 5Biochemical and Biophysical Research Communications, 1988
- Tissue factor (coagulation factor III) is present in placental microvilli and cofractionates with microvilli membrane proteinsPlacenta, 1985
- IMMUNOLOGIC AND BIOLOGICAL PROPERTIES AND CLINICAL SIGNIFICANCE OF PLACENTAL PROTEINS PP5 AND PP12aAnnals of the New York Academy of Sciences, 1983
- Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and tropho‐blastic disease: Absence of PP5 expression in the malignant trophoblastInternational Journal of Cancer, 1979